Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (271-280 of 372) with videos related to

Pageof 38
Sort By:
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens|December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationAlexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
Nature|November 15, 2016
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeysErica N Borducchi, Crystal Cabral, Kathryn E Stephenson, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
Pageof 38

Showing results (271-280 of 372) with videos related to

Sort By:
Pageof 38
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
The New England Journal of Medicine|May 19, 2016
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and ThailandMerlin L Robb, Leigh A Eller, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
Plos Pathogens|December 16, 2014
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationAlexandra Schuetz, Claire Deleage, Irini Sereti, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
Nature|November 15, 2016
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeysErica N Borducchi, Crystal Cabral, Kathryn E Stephenson, et al.
Plos Pathogens|February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and ThailandMorgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
Pageof 38